Genetic association of ACSM1 variation with schizophrenia and major depressive disorder in the Han Chinese population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 2, 2015, Pages 144-149

  Li, Wenjin ^a   Ji, Weidong ^c   Li, Zhiqiang ^a   He, Kuanjun ^a   Wang, Qingzhong ^a   Chen, Jianhua ^a,b   Qiang, Yu ^a   Feng, Guoyin ^b   Li, Xingwang ^a   Shen, Jiawei ^a   Wen, Zujia ^a   Ji, Jue ^a   Shi, Yongyong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

^c Shanghai Drug Abuse Treatment Centre   (China)

Author keywords

ACSM1; Association; Major depressive disorder; Schizophrenia; SNP

Indexed keywords

ACSM1 GENE; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ETHNIC GROUP; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS;

ACSM1 PROTEIN, HUMAN; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COENZYME A LIGASES; DEPRESSIVE DISORDER, MAJOR; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84923084586     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32291     Document Type: Article

References (34)

1. Athanasiu L, Mattingsdal M, Kahler AK, Brown A, Gustafsson O, Agartz I, Giegling I, Muglia P, Cichon S, Rietschel M, et al. 2010. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res. 44:748-753.
2. Baron M. 2001. Genetics of Schizophrenia and the New Millennium: Progress and Pitfalls. The American Journal of Human Genetics. 68:299-312.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21:263-265.
4. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry. 13:197-207.
5. Crespi B, Summers K, Dorus S. 2007. Adaptive evolution of genes underlying schizophrenia. Proceedings of the Royal Society B-Biological Sciences. 274:2801-2810.
6. Cross-Disorder Group of the Psychiatric Genomics C. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet (British edition) 381:1371-1379.
7. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, et al. 2004. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Jama. 291:2581-2590.
8. Fujino T, Takei YA, Sone H, Ioka RX, Kamataki A, Magoori K, Takahashi S, Sakai J, Yamamoto TT. 2001. Molecular identification and characterization of two medium-chain acyl-CoA synthetases, MACS1 and the Sa gene product. J Biol Chem 276:35961-35966.
9. Haketa A, Soma M, Nakayama T, Sato M, Kosuge K, Aoi N, Matsumoto K. 2004. Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J Hypertens. 22:1903-1907.
10. Hamazaki K, Hamazaki T, Inadera H. 2012. Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder. J Psychiatr Res. 46:1024-1028.
11. Iwai N, Mannami T, Tomoike H, Ono K, Iwanaga Y. 2003. An acyl-CoA synthetase gene family in chromosome 16p12 may contribute to multiple risk factors. Hypertension. 41:1041-1046.
12. Kendler Ks. 2005. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Archives of General Psychiatry. 62:529-535.
13. Kendler KS. 2001. Twin studies of psychiatric illness: An update. Archives of General Psychiatry. 58:1005-1014.
14. Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, Chalon S. 2004. Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem. 89:695-702.
15. Levinson DF. 2006. The genetics of depression: a review. Biol Psychiatry. 60:84-92.
16. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 19:519-523.
17. Milaneschi Y, Lamers F, Mbarek H, Hottenga JJ, Boomsma DI, Penninx BWJH. 2014. The effect of FTO rs9939609 on major depression differs across MDD subtypes. Mol Psychiatry 17:604-11.
18. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. 2013. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull. 39:306-318.
19. Peet M, Shah S, Selvam K, Ramchand CN. 2004. Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients. World J Biol Psychiatry. 5:92-99.
20. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics. 155:945-959.
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, et al. 2007. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. The American Journal of Human Genetics. 81:559-575.
22. Radomsky ED, Haas GL, Mann JJ, Sweeney JA. 1999. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry. 156:1590-1595.
23. Ravaja N, Kauppinen T, Keltikangas-Jarvinen L. 2000. Relationships between hostility and physiological coronary heart disease risk factors in young adults: the moderating influence of depressive tendencies. Psychol Med. 30:381-393.
24. Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ. 2000. Are the Obese at Greater Risk for Depression. American Journal of Epidemiology. 152:163-170.
25. Samaan Z, Anand SS, Zhang X, Desai D, Rivera M, Pare G, Thabane L, Xie C, Gerstein H, Engert JC, et al. 2013. The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Mol Psychiatry. 18:1281-1286.
26. Sarandol A, Kirli S, Akkaya C, Ocak N, Eroz E, Sarandol E. 2007. Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment. J Psychopharmacol. 21:857-863.
27. Schulze TG, Akula N, Breuer R, Steele J, Nalls MA, Singleton AB, Degenhardt FA, Nöthen MM, Cichon S, Rietschel M, et al. 2012. Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. The World Journal of Biological Psychiatry. 0:1-9.
28. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. 2001. DbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29:308-311.
29. Shi YY, He L. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15:97-98.
30. Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, et al. 2010. Et al.,. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol. 8:1-11.
31. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, et al. 2008. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry. 13:570-584.
32. Vaswani M, Kapur S. 2001. Genetic basis of schizophrenia: Trinucleotide repeats - An update. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25:1187-1201.
33. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 447:661-678.
34. Wood H. 2013. Neuropsychiatric disorders: Blurring diagnostic boundaries: common genetic risk variants in major psychiatric disorders. Nat Rev Neurol. 9:181.